Regional heterogeneity in the proliferative activity of human gliomas as measured by the ki-67 labeling index

Journal of Neuropathology and Experimental Neurology

Volumn 52, Issue 6, 1993, Pages 609-618

  Coons, Stephen W ^a   Johnson, Peter C ^a  

^a ST JOSEPH'S HOSPITAL AND MEDICAL CENTER   (United States)

Author keywords

Gliomas; Histologic grading; Ki 67; Proliferation; Regional heterogeneity

Indexed keywords

ARTICLE; ASTROCYTOMA; CANCER GRADING; CANCER RECURRENCE; CELL PROLIFERATION; GLIOMA; HISTOLOGY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MITOSIS; OLIGODENDROGLIOMA; PRIORITY JOURNAL;

BRAIN NEOPLASMS; GLIOMA; HUMAN; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MITOSIS; NEOPLASM PROTEINS; NUCLEAR PROTEINS;

EID: 0027367487     PISSN: 00223069     EISSN: 15546578     Source Type: Journal    
DOI: 10.1097/00005072-199311000-00008     Document Type: Article

References (46)

1. Glantz MJ, Burger PC, Herndon JE II, et al. Influence of the type of surgery on the histologic diagnosis in patients with anaplastic gliomas. Neurology 1991;41:1741-4
2. Paulus W, PeifTer J. Intratumoral histologic heterogeneity of gliomas. Cancer 1989; 64: 442-7
3. Scherer HJ. The forms of growth in gliomas and their practical significance. Brain 1940; 63: 1-35
4. Giangaspero F, Burger PC. Correlations between cytologic composition and biologic behaviour in the glioblastoma multiforme. Cancer 1983; 52: 2320-33
5. Burger PC, Kleihues P. Cytologic composition of the untreated glioblastoma with implications for evaluation of needle biopsies. Cancer 1989; 63: 2014-23
6. Bigner DD. Biology of gliomas: Potential clinical implications of glioma cellular heterogeneity. Neurosurgery 1981; 9: 320-6
7. Berkman RA, Clark WC, Saxena A, Robertson JT, Oldfield EH, AH IU. Clonal composition of glioblastoma multiforme. J Neu-rosurg 1992; 77: 432-7
8. Shapiro JR, Shapiro WR. The subpopulations and isolated cell types of freshly resected high grade human gliomas: Their influence on the tumor’s evolution in vivo and behaviour and therapy in vitro. Cancer Metastasis Rev 1985; 4: 107-24
9. Reifenberger G, Deckert M, Wechsler W. Immunohistochemical determination of protein kinase C expression and proliferative activity in human brain tumors. Acta Neuropathol 1989; 78: 166-75
10. Scheck AC, Beikman MK, Korn MC, Shapiro JR. Regional analysis of genes potentially involved in resistance to BCNU in human malignant gliomas. (Abstract) Proc Am Assoc Cancer Res 1991; 32: 358
11. Strommer K, Hamou MF, Diggelmann H, de Tribolet N. Cellular and tumoural heterogeneity of EGFR gene amplification in human malignant gliomas. Acta Neurochir 1990; 107: 82-7
12. Deckert M, Reifenberger G, Wechsler W. Determination of the proliferative potential of human brain tumors using the monoclonal antibody Ki-67. J Cancer Res Clin Oncol 1989; 115: 179-88
13. Coons SW, Johnson PC. Regional heterogeneity in the KI67 labeling indices of gliomas. (Abstract) J Neuropathol Exp Neurol 1992; 51: 331
14. Allegranza A, Girlando S, Arrigoni GL, et al. Proliferating cell nuclear antigen expression in central nervous system neoplasms. Virchows Arch [A] 1991; 419: 417-23
15. Sidransky D, Mikkelsen T, Schwechheimer K, Rosenblum ML, Cavanee W, Vogelstein B. Clonal expansion of p53 mutant cells is associated with brain tumour progression. Nature 1992; 355: 846-7
16. Stavrou D, Bise K, Groeneveld J, et al. Antigenic heterogeneity of human brain tumors defined by monoclonal antibodies. Anticancer Res 1989; 9: 1489-96
17. Benediktsson G, Blomquist E, Carlsson J. Heterogeneity in cell loss and frequency of slow growing colonies of human glioma cell lines. Some effects of radiation. Anticancer Res 1989; 9: 1483-8
18. Shapiro JR, Scheck AC, Mehta BM, Moots PL, Fiola MR. Minor subpopulation of intrinsically chemoresistant and radioresistant cells in primary gliomas become the dominant population in recurrent tumors. (Abstract) J Cancer Res Clin Oncol 1990 (Suppl 2); 116: 1135
19. Daumas-Duport C, Monsaingeon V, N’Guyen JP, Missir O, Szikla G. Some correlations between histological and CT aspects of cerebral gliomas contributing to the choice of significant trajectories for stereotactic biopsies. Acta Neurochir 1984; 33: 185-94
20. Chandrasoma PT, Smith MM, Apuzzo LJ. Stereotactic biopsy in the diagnosis of brain masses: Comparison of results of biopsy and resected surgical specimen. Neurosurgery 1989; 23: 160-5
21. Scerrati M, Rossi GF, Roselli R. The. spatial and morphological assessment of cerebral neuroectodermal tumors through stereotactic biopsy. Acta Neurochir 1987; 39: 28-33
22. Gerdes J, Schlueter C, Duchrow M, et al. Immunobiochemical and molecular biologic characterization of the cell proliferation-associated nuclear antigen that is denned by monoclonal antibody Ki-67. Am J Pathol 1991; 138: 867-73
23. Verheijen R, Kuipers HJH, Schlingemann RO, et al. Ki-67 detects a nuclear matrix-associated proliferation-related antigen. J Cell Sci 1989; 92: 123-30
24. Gerdes J, Lemke H, Baisch H, Wacker HH, Schwab U, Stein H. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 1984; 133: 1710-15
25. Daumas-Duport C. Histological grading of gliomas. Curr Opin Neurol Neurosurg 1992; 5: 924-31
26. Hoshino T. Cell kinetics of glial tumors. Rev Neurol 1992; 148: 396-101
27. Shibuya M, Stoyuki I, Miwa T, Davis RL, Wilson CB, Hoshino T. Proliferative potential of brain tumors. Cancer 1993; 71: 199-206
28. Hara A, Hirayama H, Sakai N, Yamada H, Tanaka T, Mori H. Correlation between nucleolar organizer region staining and Ki-67 immunostaining in human gliomas. Surg Neurol 1990; 33: 320-4
29. Louis DN, Edgerton S, Thor AD, Hedley-Whyte ET. Proliferating cell nuclear antigen and Ki-67 immunohistochemistry in brain tumors: A comparative study. Acta Neuropathol 1991; 81: 675-9
30. Coons SW, Davis JR, Way DL. Correlation of DNA content and histology in prognosis of astrocytomas. Am J Clin Pathol 1988; 90: 289-93
31. Parkins CS, Darling JL, Gill SS, Revesz T, Thomas DG. Cell proliferation in serial biopsies through human brain tumours: Measurement using Ki67 antibody labelling. Br J Neurosurg 1991; 5: 289-98
32. Ringertz N. "Grading" of gliomas. Acta Pathol Microbiol Scand 1950; 27: 51-64
33. Burger PC, Vogel FS, Green SB, Strike TA. Glioblastoma multiforme and anaplastic astrocytoma: Pathologic criteria and prognostic implication. Cancer 1985; 56: 1106-11
34. Bishop M, de la Monte SM. Dual lineage of astrocytomas. Am J Pathol 1989; 135: 517-27
35. de la Monte SM. Uniform lineage of oligodendrogliomas. Am J Pathol 1989; 135: 529-10
36. Shaw EG, Scheithauer BW, O’Fallon JR, Tazalaar HD, David DH. Oligodendrogliomas: The Mayo Clinic experience. J Neurosurg 1992; 76: 428-34
37. Svien HJ, Mabon RF, Kernohan JW, Adson AW. Symposium on a new and simplified concept of gliomas. In: Proceedings of the staff meetings at the Mayo Clinic, vol 24. Rochester, MN: Mayo Clinic, 1949: 54-63
38. Earnest F III, Kernohan JW, Craig WM. Oligodendrogliomas. A review of two hundred cases. Arch Neurol Psychiatry 1950; 63: 964-76
39. Kernohan JW. Tumors of the CNS. In: Proceedings of the staff meetings of the Mayo Clinic, vol 13. Rochester, MN: Mayo Clinic, 1938:71-5
40. Kros JM, van Eden CG, Vissers CJ, Mulder AH, van der Kwast TH. Prognostic relevance of DNA flow cytometry in oligodendroglioma. Cancer 1992; 69: 1791-8
41. Daumas-Duport C, Scheithauer B, O’Fallon J, Kelly P. Grading of astrocytomas. A simple and reproducible method. Cancer 1988; 62: 2152-65
42. Kleihues P, Burger PC, Scheithauer BW. Histological typing of tumours of the central nervous system. Geneva: World Health Organization, 1993 (in press)
43. Coons SW, Johnson PC. Regional heterogeneity in flow cytometric measurements of DNA ploidy and proliferation in human gliomas. Am Assoc Cancer Res 1991; 32: Abstract 183
44. Shapiro JR, Scheck AC, Mehta BM, Moots PL, Fiola MR. Tumor heterogeneity and intrinsically chemoresistant subpopulation in freshly resected human malignant gliomas. In: Sudilovsky O, Pitot HC, Liotta LA, eds. Boundaries between promotion and progression during carcinogenesis. New York: Plenum Press, 1991: 243-62
45. Bell C, Frost P, Kerbel RS. Cytogenetic heterogeneity of genetically marked and metastatically competent "dominant" tumor cell clones. Cancer Genet Cytogenet 1991; 59: 153-61
46. Nowell P. The clonal evolution of tumor cell populations. Science 1976; 194: 23-8